Apple Inc. (AAPL), The Walt Disney Company (DIS): Where’s My Mac N’ Cheese?!
How I miss the NBC show, "30 Rock". Suave exec Jack Donaghy asks head writer Liz Lemon if she watches CNBC. "No, CNBC gives me a headache.
Posts Tagged ‘Pfizer Inc (PFE)’
GlaxoSmithKline plc (ADR) (GSK): Why Investors Should Consider It
GlaxoSmithKline plc (ADR) (NYSE:GSK) is a pharmaceutical and healthcare company headquartered in the United Kingdom.
Onyx Pharmaceuticals, Inc. (ONXX), Pfizer Inc. (PFE), And Kidney Cancer’s Top Bets
As I noted nine weeks ago, cancer statistics are both staggering and disappointing.
Merck & Co., Inc. (MRK), Novartis AG (ADR) (NVS), Pfizer Inc. (PFE): Six Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part II
The healthcare sector has been known for paying dependable dividends and producing strong total returns over time.
The Coca-Cola Company (KO), General Electric Company (GE): The Dow (.DJI)’s 5 Most Loved Stocks
If last decade was the "lost decade," then this decade is certainly something of a rebirth for the markets, which have more than doubled off their recession lows.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): Last Week’s Big Dow (.DJI) Losers
After receiving news of lower-than-expected jobless claims, higher-than-expected job growth, and interest-rate cuts by the European Central Bank to 0.5%, the U.S.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): FDA Approves Powerful New Cholesterol Drug
Merck & Co., Inc. (NYSE:MRK) gained Food and Drug Administration approval for its powerful new cholesterol drug Liptruzet, a combination of two already-approved drugs, Pfizer...
Caterpillar Inc. (CAT)’s Surge Pushes Dow (.DJI) 15K
It took a lot longer than many pundits predicted, but we finally hit that ballyhooed mark: Dow 15,000.
Merck & Co., Inc. (MRK) Down, Could’ve Fallen Worse
The problem was the other drugs didn't make up nearly enough of the Singulair loss.
Eli Lilly & Co. (LLY), GlaxoSmithKline plc (ADR) (GSK), And Why You Don’t Have to Run a Cartel to Make Big Profits in Drugs
The market for prescription and over-the-counter drugs is huge and hugely profitable.
Amgen, Inc. (AMGN): What’s Its Next Catalyst?
Amgen, Inc. (NASDAQ:AMGN) stock has been on a bit of a roller coaster lately.
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY) & Other Names To Know: A Full Breakdown
Investing in biotech companies can be intimidating, especially for investors without a science background. But there's hope.
Johnson & Johnson (JNJ), Pfizer Inc. (PFE): Take Two Dividend Stocks and Call Me in the Morning
Dividend stocks can be a great addition to your portfolio, especially pharmaceutical dividend stocks that offer a bit of stability in rocky times.
Who’s Suing Novartis AG (ADR) (NVS), And Why?
Would you hold a pharmaceutical product presentation in Hooters? That's just one of many alleged instances that the U.S.
Pfizer Inc. (PFE), Novartis AG (ADR) (NVS), GlaxoSmithKline plc (ADR) (GSK) & Big Pharma’s Kickback Conundrum
Big pharma is a controversial industry. Along with tobacco companies, they are some of the most vilified businesses in the world.
Auto News: Tesla Motors Inc (TSLA)’s Subpoena, General Motors Company (GM) & Ford Motor Company (F)
Editor's Note: Related tickers: Tesla Motors Inc (NASDAQ:TSLA), General Motors Company (NYSE:GM), Ford Motor Company (NYSE:F), Cardiovascular Systems Inc (NASDAQ:CSII), Pfizer...
Biopharma News: Arena Pharmaceuticals, Inc. (ARNA)’s Update, New VIVUS, Inc. (VVUS) Deal & More
Editor's Note: Related tickers: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), VIVUS, Inc. (NASDAQ:VVUS), Johnson & Johnson (NYSE:JNJ), Orexigen Therapeutics, Inc.
D.R. Horton, Inc. (DHI), Verizon Communications Inc. (VZ), Pfizer Inc. (PFE): Exploding Home Prices Support Stocks
Blue-chip stocks are holding onto record highs this afternoon after new data showed that home prices are growing at the fastest rate in nearly seven years.
A Game-Changer For Pfizer Inc. (PFE)
The wealth-building power of compound interest will never cease to amaze me.
Pfizer Inc. (PFE) Holding Dow Jones Industrial Average (.DJI) Back
The Dow Jones Industrial Average (Dow Jones Indices:.DJI) is unchanged following a worse-than-expected earnings release from Pfizer Inc.
How Will Merck & Co., Inc. (MRK)’s Earnings Fare Tomorrow?
Tomorrow, Merck & Co., Inc. (NYSE:MRK) will release its latest quarterly results.
GlaxoSmithKline plc (GSK), Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Buy These Patent-Cliff Proof Stocks
Patent expiration is one of the major issues faced by pharma companies, which increases the competition from generic medicines and eventually leads to downfall in their sales.
Pfizer Inc. (PFE): Dow (.DJI) May Open Flat As It Disappoints
LONDON -- Stock index futures at 7 a.m.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY): A New Diabetes Duo Emerges
That's the message from today's announcement that Pfizer Inc. (NYSE:PFE) is out-licensing its diabetes drug candidate ertugliflozin to Merck & Co., Inc. (NYSE:MRK).
Raptor Pharmaceutical Corp. (RPTP), AVEO Pharmaceuticals, Inc. (AVEO) & Two FDA Decisions You Can’t Afford to Miss This Week
Last week we focused on five can't-miss earnings reports.
AstraZeneca plc (ADR) (AZN), Exelixis, Inc. (EXEL), Pfizer Inc. (PFE) & Tackling Cancer: Thyroid Cancer’s Biggest Current and Upcoming Players
As I noted eight weeks ago, cancer statistics are both staggering and disappointing.
AbbVie Inc (ABBV)’s First Quarter: The Full Story of Humira And The 7 Dwarfs
In its first four months of existence, AbbVie Inc (NYSE:ABBV) rewarded investors with gains of almost 26%. Going into month five, those gains seem likely to increase.
Verizon Communications Inc. (VZ), Pfizer Inc. (PFE), AT&T Inc. (T): What Makes Dow (.DJI) Dividends So Important
Many investors rely on dividends for the income they need from their portfolios.
Pfizer Inc. (PFE), Baxter International (BAX), Quest Diagnostics (DGX) & Collecting Dividends From the Healthcare Sector
Continuing on with the dividend trend that my recent articles have been focusing upon, I’d like to now take a look at some solid healthcare companies.
Merck & Co., Inc. (MRK): How This Can Eventually Lead To Healthy Returns
In the big pharma sector, it can oftentimes be hit or miss when seeking the next big growth stock.
Avanir Pharmaceuticals, Inc. (AVNR), Medivation Inc (MDVN) & This Week In Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Pfizer Inc. (PFE), Wal-Mart Stores, Inc. (WMT): The Danger of Low Dividends
Earnings among S&P 500 companies are at an all-time high.
Johnson & Johnson (JNJ): Buying Isn’t for Growth Investors
If there's one health-care stock every investor knows by name, it's Johnson & Johnson (NYSE:JNJ).
Novartis AG (ADR) (NVS), Sanofi SA (ADR) (SNY), Regeneron Pharmaceuticals Inc (REGN): Three Potential Game Changers for America’s No. 1 Killer
Heart disease kills nearly 600,000 Americans every year, making it the nation's No. 1 cause of death, according to the Centers for Disease Control and Prevention.
Ralph Lauren Corp (RL): The SEC Changes Its Course
Depending on how often you meet in glass-walled conference rooms, $125 might seem like a lot for a shirt.
Amgen, Inc. (AMGN): Is It a Buy Now?
When it comes to biotechs, Amgen, Inc. (NASDAQ:AMGN) qualifies for the senior citizen discount.
Eli Lilly & Co. (LLY): Will The Big Bets Pay Off?
Tomorrow, Eli Lilly & Co. (NYSE:LLY) will release its latest quarterly results.
GameStop Corp. (GME), Pfizer Inc. (PFE) and More: iShares Bolsters Factor ETF Lineup With 5 New Funds
BlackRock, Inc. (NYSE:BLK) iShares unit, the world's largest ETF issuer, added to its lineup of factor-driven ETFs today with the debut of five new funds.
Pfizer Inc. (PFE), Bristol Myers Squibb Co. (BMY), and Alzheimer’s Milkshakes: The Growth of Medical Nutrition
A milkshake is not foremost on most people’s list of treatments for the neurological disorder Alzheimer’s.
Gilead Sciences, Inc. (GILD) or Biogen Idec Inc. (BIIB)? This Is What the Perfect Biotech Would Look Like
I don't know about you, but I'm pretty stoked for the NFL draft this Thursday.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK) & More: Drug Stocks on Citi’s Dividend Buy List
Barron's recently posted Citi's updated list of large, financially strong, high-yielding, dividend-paying companies.
This Day in History: Pfizer Inc. (PFE)’s Start, McDonald’s Corporation (MCD) Goes Public, and General Motors Company (GM) Dominates
Two members of the Dow Jones Industrial Average got started on their path to business leadership on April 21, and one former member reached one of the most impressive milestones...
Sarepta Therapeutics Inc (SRPT): FDA Says, “Call Me Maybe”
A lot has been written this week -- at The Fool and elsewhere -- about Sarepta Therapeutics Inc (NASDAQ:SRPT)' update on its meeting with the Food and Drug Administration.
Amgen, Inc. (AMGN): Is It Too Hot to Handle?
Shares of Amgen, Inc. (NASDAQ:AMGN) have returned over 65% in the past year; 109% if dividends are included. The S&P 500 has returned just over 13%.
Alkermes Plc (ALKS), Pfizer Inc. (PFE), Eli Lilly & Co. (LLY): These Biotech Investors Are Far From Depressed
The drug produced a statistically significant improvement in three different rating scales for depression compared to placebo.
Abbott Laboratories (ABT): Will This Stock Hit New Highs After Earnings?
On Wednesday, Abbott Laboratories (NYSE:ABT) will release its latest quarterly results.
Pfizer Inc. (PFE), Exxon Mobil Corporation (XOM) & More Low Risk Dividend Growers From BlackRock
BlackRock focuses on low volatility dividend growers.
ACADIA Pharmaceuticals Inc. (ACAD), Astex Pharmaceuticals, Inc. (ASTX), Pfizer Inc. (PFE), and More: This Week in Biotech
With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Pfizer Inc. (PFE), Hewlett-Packard Company (HPQ), and How The Dogs of the Dow Jones Industrial Average (.DJI) Beat Their Index This Week
The "Dogs of the Dow" is the name of one of the simplest dividend strategies for beating the market.
Alcoa Inc (AA), Pfizer Inc. (PFE), Hewlett-Packard Company (HPQ), And The Rest of Last Week’s Big Dow Jones Industrial Average 2 Minute (.DJI) Losers
This week officially kicked off earnings season, after Alcoa Inc (NYSE:AA) released its reports following the closing bell on Monday.
